Patients with an intensive-metabolizing CYP2D6 phenotype have demonstrated higher levels of hydromorphone during hydrocodone metabolism compared to inadequate metabolizers.[four] Even so, the existing knowledge does not advocate for modified hydrocodone dosing recommendations for patients with regarded CYP2D6 polymorphisms.Hydrocodone withdrawal